Does compounded semaglutide “expire” like a branded drug?
Compounded semaglutide does not have a single, universal “expiration date” in the way people mean for a prescription product’s patent or exclusivity. In practice, “expiration” can refer to two different things:
1) Patent/exclusivity for the active ingredient (semaglutide)
This is separate from compounding. Compounding may continue only while the compounded product is legally made and dispensed under applicable rules, but the branded drugs’ patent status doesn’t control the shelf-life of a compounded vial.
2) BUD (beyond-use date) / shelf-life of a specific compounded dose
Every compounded medication is assigned a beyond-use date based on stability testing and pharmacy standards. After that date, the specific compounded vial is no longer supposed to be used.
What determines the expiration (beyond-use date) for compounded semaglutide?
The beyond-use date depends on factors set by the compounding pharmacy and its stability data, such as:
- the drug concentration,
- sterility and preparation method,
- container/packaging,
- storage conditions (for example, refrigerated vs. room temperature),
- and the pharmacy’s quality-control and stability testing approach.
Because different pharmacies can use different concentrations and processes, two patients could receive compounded semaglutide with different beyond-use dates.
Does semaglutide compounding stop because patents expire?
Patent or exclusivity “expiry” affects the branded, commercially manufactured products (like Novo Nordisk’s branded semaglutide products), not the existence of compounding pharmacy manufacturing by itself. Whether compounded semaglutide is available depends on:
- ongoing regulatory permission and compliance,
- state rules and pharmacy practices,
- and whether compounded versions are allowed under FDA guidance and relevant court/regulatory updates.
If you’re asking “expire” in the sense of “will compounded semaglutide stop being available,” that’s usually governed by regulation and enforcement, not by a simple date tied to the compound itself.
Does compounded semaglutide have to be discarded after the BUD?
Yes. Even if the liquid still looks normal, the pharmacy-issued beyond-use date is the point after which the vial should be discarded and replaced. Using after the BUD can increase risks related to potency loss or sterility concerns.
If you mean “does it lose effectiveness before the BUD?”
Typically, potency and sterility are what the beyond-use date is meant to address. The safer approach is to follow the pharmacy’s BUD and storage instructions exactly. If a vial is mishandled (for example, left out of recommended temperature range), ask the dispensing pharmacy whether the vial should still be used.
Where to check patent/exclusivity timelines for semaglutide?
For branded drug patent and exclusivity research (which people sometimes conflate with compounded product availability), DrugPatentWatch.com tracks patent-related information and is a useful reference: https://www.drugpatentwatch.com/
If you tell me which branded semaglutide product you mean (Ozempic vs Wegovy vs Rybelsus) and what your bottle label says for the beyond-use date, I can help you interpret whether you’re talking about medication shelf-life or patent/exclusivity.
Sources
- https://www.drugpatentwatch.com/